Emerging evidence highlights that inflammation is increasingly recognized as a hallmark of PAH, with infiltrating immune cells (e.g., T lymphocytes, macrophages) secreting pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β [5,6]. Here, TNF is linked to pulmonary arterial hypertension.